Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Healthcare Report.
Press releases published on May 8, 2025
Privia Health Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
Strong First Quarter Performance and Operating Execution Enters the State of Arizona Full-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged ARLINGTON, Va., May 08, 2025 (GLOBE NEWSWIRE) -- …
Dentsply Sirona Reports First Quarter 2025 Results
GlobeNewswire
·
May 8, 2025
Net sales of $879 million decreased (7.7%), organic sales decreased (4.4%) including a (4.0%) Byte sales impact GAAP gross margin of 53.0%, GAAP net income of $20 million or $0.10 per share Adjusted gross margin of 56.3%, adjusted EBITDA margin of 19.0%, …
Sagimet Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Updates
GlobeNewswire
·
May 8, 2025
SAN MATEO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today reported financial results …
Enovis Announces First Quarter 2025 Results
GlobeNewswire
·
May 8, 2025
Continued commercial momentum with first-quarter sales growth of 8% on a reported basis and strong adjusted EBITDA margin expansion First-quarter Reconstructive sales grew 11% year-over-year on a reported basis Appointed Damien McDonald as CEO, effective …
NewBiologix Licenses Xcell-Eng-HEK293 Cell Line to ReciBioPharm for Development and Manufacture of Adeno-Associated Virus (AAV) Therapeutics
GlobeNewswire
·
May 8, 2025
Provides ReciBioPharm’s customers with access to NewBiologix’s Xcell-Eng-HEK293 cell lines for advanced therapies Complements and further expands ReciBioPharm’s AAV offering Achieves industry-leading results across multiple AAV programs LAUSANNE, …